Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


US FDA's Label Updating Effort Needs Legislation To Impact Generics

Executive Summary

Generic labels can't easily be changed if reference product is withdrawn, meaning legislative fix is needed to add current recommendations to outdated labels.

Related Content

Generic Labeling Problems Targeted In US FDA Budget Request
Cancer Drugs: US FDA Looks Outside For Help On Generic Labeling Updates
US FDA May Ask Congress For More Resources After Withdrawing Generic Label Reg
US FDA Looks To Proactively Update Old Generic Drug Labels Under Pilot
Generic Labeling Rule Dies In Latest Reg Agenda, But Electronic Labeling Is Reborn
Labeling Updates For Old Drugs Could Be Faster Under Streamlining Proposal
Implementing User Fees Should Be Lighter Lift For FDA This Time Around; Bill Heads To White House
Woodcock, Califf Give Thumbs Up To Certain 21st Century Cures Provisions
Will PDUFA VI Fee Structure Changes Slow Revenue Growth?
FDA Wants All Drug Manufacturers To Adopt Highlights Labeling Format





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts